Publications by authors named "Jing-Xin Li"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

973,098

Total Likes

21,888

Extended Reach

1,931,414

Social Features

152
S
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
Feng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, Li-Hua Hou, Wen-Juan Wang, Jing-Xin Li, Shi-Po Wu, Bu-Sen Wang, Zhao Wang, Lei Wang

Lancet· June 2020

Videos about Article: user user

2 42 150 44 365 40

View All Article and Social Media Activity
A
Adverse reaction characteristics of five COVID-19 vaccines across different technology platforms: a pooled analysis of nine clinical trials.
Yue Liu, Qian Liu, Lai-Run Jin, Wei-Wei Han, Ming-Wei Wei, Jing-Xin Li

Expert Rev Vaccines· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a recombinant gE-Fc fusion protein subunit vaccine for herpes zoster in adults ≥50 years of age: a randomised, active-controlled, non-inferiority trial.
Peng-Fei Jin, Ya-Ru Quan, Shi-Xin Xiu, Xian-Min Jiang, Hong-Xing Pan, Li Chen, Ling Peng, Chang-Gui Li, Jing-Xin Li

Nat Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of basic type of intermittent exotropia on myopic shift in children: a 12-month observational study.
Jing-Xin Li, Xiang-Xiang Liu, Jie Hao, Hui-Xin Li, Qiong-Yue Zhang, Lei Li

Front Pediatr· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Accommodation and Convergence with Axial Length Elongation in Children with Basic Intermittent Exotropia: A 12-Month Observational Study.
Jing-Xin Li, Jie Hao, Xiang-Xiang Liu, Jie Hong, Hui-Xin Li, Lei Li

Ophthalmic Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies.
Abundio Balgos, Suad Hannawi, Wen-Li Chen, Alaa Abuquta, Linda Safeldin, Anjuli May Jaen, Yong Liu, Jing-Xin Li

Expert Rev Vaccines· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of pre-mRNA splicing and its study tools in plants.
Yue Liu, Sally Do, Henry Huynh, Jing-Xin Li, Ying-Gao Liu

Adv Biotechnol (Singap)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos).
Yi Fang, Jing-Xin Li, Davone Duangdany, Yang Li, Xi-Lin Guo, Si-Jun Liu, Hang-Wen Li

EClinicalMedicine· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov.
Shen-Yu Wang, Wen-Qing Liu, Yu-Qing Li, Jing-Xin Li, Feng-Cai Zhu

Expert Rev Vaccines· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial.
Jing-Xin Li, Li-Hua Hou, Jin-Bo Gou, Zun-Dong Yin, Shi-Po Wu

Lancet Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental Impact Assessment for the Use of an Orally Aerosolized Adenovirus Type-5 Vector-Based COVID-19 Vaccine in Randomized Clinical Trials.
Xin Xia, Zhong-Ming Tan, Peng Wan, Hao Zheng, Rong Tang, Xi-Ling Guo, Xiao-Long Li, Jing-Xin Li

J Infect Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial.
Jun-Dong Wu, Jing-Xin Li, Jian Liu, Hao-Meng Wang, Guang-Hui Zhou, Jin Li, Tie-Liang Ma, Li-Feng Xu

Lancet Infect Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of antibody persistency through one year between one-dose and two-dose regimens of Ad5-nCoV vaccine for COVID-19.
Jia-Lu Feng, Wen-Juan Wang, Peng-Fei Jin, Hui Zheng, Lai-Run Jin, Zhuo-Pei Li, Jing-Xin Li

Hum Vaccin Immunother· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial.
Rong Tang, Hui Zheng, Bu-Sen Wang, Jin-Bo Gou, Xi-Ling Guo, Zhuo-Pei Li, Jing-Xian Liu, Li-Hua Hou, Jing-Xin Li

Lancet Respir Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, immunobridging trial.
Yan-Fei Wu, Ming-Wei Wei, Rui-Jie Wang, Xi-Ling Guo, Hong-Xing Pan, Xiao-Long Li, Li Zhou, Jing-Xin Li

Expert Rev Vaccines· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trial.
Peng-Fei Jin, Xi-Ling Guo, Jin-Bo Gou, Li-Hua Hou, Zhi-Zhou Song, Jing-Xian Liu, Jing-Xin Li

Lancet Reg Health West Pac· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial.
Yu-Zhou Gui, Xue-Ning Li, Jing-Xin Li, Ming-Yun Shen, Mei-Wei Zhang, Hui Li, Liang Pan, Li-Yu Liang, Gang-Yi Liu, Fei Liang, Hang-Wen Li

EBioMedicine· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High precision tracking analysis of cell position and motion fields using 3D U-net network models.
Li-Xin Yuan, Hong-Mei Xu, Zi-Yu Zhang, Xu-Wei Liu, Jing-Xin Li

Comput Biol Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toluene degradation using plasma-catalytic hybrid system over Mn-TiO and Fe-TiO.
Li-Qiang Qi, Zhe Yu, Qi-Hao Chen, Jing-Xin Li, Hao-Bo Xue, Feng Liu

Environ Sci Pollut Res Int· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning-Based Prediction of Acute Kidney Injury Following Pediatric Cardiac Surgery: Model Development and Validation Study.
Xiao-Qin Luo, Yi-Xin Kang, Shao-Bin Duan, Ping Yan, Guo-Bao Song, Jing-Xin Li

J Med Internet Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-head comparisons of the neutralizing antibody against SARS-CoV-2 variants elicited by four priming-boosting regimens.
Hu-Dachuan Jiang, Xi-Ling Guo, Peng-Fei Jin, Rong Tang, Jing-Xin Li

Emerg Microbes Infect· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and above.
Zhuo-Pei Li, Yun-Feng Shi, Li-Hua Hou, Peng-Fei Jin, Shi-Hua Ma, Li-Li Wang, Jing-Xin Li

Expert Rev Vaccines· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised controlled trial: effect of metformin add-on therapy on functional cure in entecavir-treated patients with chronic hepatitis B.
Wei Zhang, Yuan-Yuan Li, Qing-Hua Shang, Lin Qi, Mi-Mi Sun, Jing-Xin Li, Li Tang

Ann Hepatol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial.
Jing-Xin Li, Shi-Po Wu, Xi-Ling Guo, Rong Tang, Bao-Ying Huang, Li-Hua Hou, Jing-Xian Liu, Zhuo-Pei Li

Lancet Respir Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The S-Trimer (SCB-2019) COVID-19 vaccine and reinfection with SARS-CoV-2.
Jing-Xin Li, Feng-Cai Zhu

Lancet Infect Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials.
Feng-Cai Zhu, Hao Zeng, Jing-Xin Li, Bin Wang, Fan-Yue Meng, Hao-Yu Liang, Pei Liu, Liu-Sheng Peng, Hai-Bo Li

Vaccine· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis